Boston Scientific announces conference call discussing second quarter 2025 results

Boston Scientific (NYSE:BSX) has scheduled a conference call to discuss its second quarter 2025 financial results and business highlights.

Rhea-AI Summary

Boston Scientific (NYSE:BSX) has scheduled a conference call to discuss its second quarter 2025 financial results and business highlights. The call will take place on July 23, 2025, at 8:00 a.m. ET, featuring Chairman and CEO Mike Mahoney and CFO Jon Monson.

The company will release its Q2 2025 financial results prior to the conference call. Investors can access both the live webcast and replay through the company's investor relations website, with the replay becoming available approximately one hour after the event concludes.

Argus Session date unavailable

-2.45% session move Open Argus

Details

News Market Reaction – BSX

The recorded move for BSX in the trading session of this news was -2.45%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MARLBOROUGH, Mass., July 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2025, on Wednesday, July 23, 2025, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter on July 23 prior to the conference call.

A live webcast and replay for the event will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-second-quarter-2025-results-302495273.html

SOURCE Boston Scientific Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Boston Scientific (BSX) reporting Q2 2025 earnings?

Boston Scientific will report Q2 2025 earnings on July 23, 2025, before the conference call scheduled for 8:00 a.m. ET.

Who will host Boston Scientific's Q2 2025 earnings call?

The call will be hosted by Mike Mahoney, chairman and CEO, and Jon Monson, executive vice president and CFO.

How can investors access Boston Scientific's Q2 2025 earnings call?

Investors can access the live webcast and replay through Boston Scientific's investor relations website.

When will the replay of BSX's Q2 2025 earnings call be available?

The replay will be available approximately one hour following the completion of the conference call.